首页> 外文期刊>Science >Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II
【24h】

Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II

机译:真菌防御素Plectasin靶向细菌细胞壁前体脂质II

获取原文
获取原文并翻译 | 示例
       

摘要

Host defense peptides such as defensins are components of innate immunity and have retained antibiotic activity throughout evolution. Their activity is thought to be due to amphipathic structures, which enable binding and disruption of microbial cytoplasmic membranes. Contrary to this, we show that plectasin, a fungal defensin, acts by directly binding the bacterial cell-wall precursor Lipid II. A wide range of genetic and biochemical approaches identify cell-wall biosynthesis as the pathway targeted by plectasin. In vitro assays for cell-wall synthesis identified Lipid II as the specific cellular target. Consistently, binding studies confirmed the formation of an equimolar stoichiometric complex between Lipid II and plectasin. Furthermore, key residues in plectasin involved in complex formation were identified using nuclear magnetic resonance spectroscopy and computational modeling.
机译:宿主防御肽(例如防御素)是先天免疫的组成部分,并在整个进化过程中保留了抗生素活性。它们的活性被认为是由于两亲性结构引起的,所述两亲性结构能够结合和破坏微生物细胞质膜。与此相反,我们表明,真菌防御素Plectasin通过直接结合细菌细胞壁前体脂质II发挥作用。广泛的遗传和生化方法将细胞壁生物合成确定为Plectasin靶向的途径。细胞壁合成的体外测定确定脂质II是特定的细胞靶标。一致地,结合研究证实了脂质II和Plectasin之间形成等摩尔化学计量的配合物。此外,利用核磁共振波谱法和计算模型鉴定了lectlectasin中参与复杂形成的关键残基。

著录项

  • 来源
    《Science》 |2010年第5982期|P.1168-1172|共5页
  • 作者单位

    Pharmaceutical Microbiology Section, Institute for Medical Microbiology, Immunology, and Parasitology, University of Bonn, D-53115 Bonn, Germany;

    rnStatens Serum Institut, 2300 Copenhagen S, Denmark;

    rnDepartment of Biotechnology, Chemistry, and Environmental Engineering, Aalborg Univer- sity, DK-9000 Aalborg, Denmark;

    rnPharmaceutical Microbiology Section, Institute for Medical Microbiology, Immunology, and Parasitology, University of Bonn, D-53115 Bonn, Germany;

    rnPharmaceutical Microbiology Section, Institute for Medical Microbiology, Immunology, and Parasitology, University of Bonn, D-53115 Bonn, Germany;

    rnPharmaceutical Microbiology Section, Institute for Medical Microbiology, Immunology, and Parasitology, University of Bonn, D-53115 Bonn, Germany;

    rnPharmaceutical Microbiology Section, Institute for Medical Microbiology, Immunology, and Parasitology, University of Bonn, D-53115 Bonn, Germany;

    rnNovozymes AS, DK-2880 Bagsvaerd, Denmark;

    rnNovozymes AS, DK-2880 Bagsvaerd, Denmark;

    rnNovozymes AS, DK-2880 Bagsvaerd, Denmark;

    rnNovozymes AS, DK-2880 Bagsvaerd, Denmark;

    rnNovozymes AS, DK-2880 Bagsvaerd, Denmark;

    rnDepartment of Chemistry, Faculty of Science, Utrecht University, 3584 CH Utrecht, Netherlands;

    rnNovozymes AS, DK-2880 Bagsvaerd, Denmark;

    rnStatens Serum Institut, 2300 Copenhagen S, Denmark Novozymes AS, DK-2880 Bagsvaerd, Denmark;

    rnNovozymes AS, DK-2880 Bagsvaerd, Denmark;

    rnPharmaceutical Microbiology Section, Institute for Medical Microbiology, Immunology, and Parasitology, University of Bonn, D-53115 Bonn, Germany;

    rnNovozymes AS, DK-2880 Bagsvaerd, Denmark;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:54:32

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号